IpiNovyx Bio
West Nyack
About IpiNovyx Bio
IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune and inflammatory diseases. It helps create inhibitors to selectively target the immunoproteasome and modulate specific immune cell types for patients to recover from autoimmune and inflammatory diseases and improve their health.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $10.0M
- Funding stage: Seed
- Last round: Seed (Oct 2021)
- Website: ipinovyxbio.com
Industries & Categories
Biopharma, Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/ipinovyx-bio-6729 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.